Reference
Lewicki M, et al. Severe hypokalemia due to secondary mineralocorticoid excess syndrome (MCES) following abiraterone therapy in a patient with prostate cancer: a case report. Endokrynologia Polska 73 (Suppl.): 27, May 2022. Available from: URL: https://journals.viamedica.pl/endokrynologia_polska/article/view/89833/66709 [abstract]
Rights and permissions
About this article
Cite this article
Abiraterone. Reactions Weekly 1914, 15 (2022). https://doi.org/10.1007/s40278-022-18601-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-18601-3